P63-negative pulmonary NUT carcinoma arising in the elderly: a case report

[1]  G. Pelosi,et al.  Immunohistochemical neuroendocrine marker expression in primary pulmonary NUT carcinoma: a diagnostic pitfall , 2020, Histopathology.

[2]  S. Sallan,et al.  An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients , 2019, JNCI cancer spectrum.

[3]  C. Messina,et al.  NUT midline carcinoma: Current concepts and future perspectives of a novel tumour entity. , 2019, Critical reviews in oncology/hematology.

[4]  A. Toss,et al.  NUT midline carcinoma of the head and neck: current perspectives , 2019, OncoTargets and therapy.

[5]  J. Carr,et al.  Registry , 2019, Definitions.

[6]  C. French.  NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment , 2018, Pathology international.

[7]  G. Rath,et al.  Patterns of care and impact of prognostic factors in the outcome of NUT midline carcinoma: a systematic review and individual patient data analysis of 119 cases , 2017, European Archives of Oto-Rhino-Laryngology.

[8]  E. Borgen,et al.  NUT expression in primary lung tumours , 2015, Diagnostic Pathology.

[9]  J. Austin,et al.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[10]  M. Mino‐Kenudson,et al.  Primary Pulmonary NUT Midline Carcinoma: Clinical, Radiographic, and Pathologic Characterizations , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[11]  M. Yunokawa,et al.  Clinicopathological features in young patients treated for small-cell lung cancer: significance of immunohistological and molecular analyses. , 2014, Clinical lung cancer.

[12]  C. Antonescu,et al.  Midline carcinoma of children and young adults with NUT rearrangement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  J. Fletcher,et al.  BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. , 2003, Cancer research.

[14]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[15]  P. D. Dal Cin,et al.  BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). , 2001, The American journal of pathology.

[16]  Y. Lau,et al.  Disseminated mediastinal carcinoma with chromosomal translocation (15;19). A distinctive clinicopathologic syndrome , 1993, Cancer.

[17]  Y. Ohtsuki,et al.  Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. , 1991, Cancer research.

[18]  U. Kees,et al.  Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). , 1991, The American journal of pediatric hematology/oncology.